Mosaburo相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Pre-treatment NLR and Changes in NLR Are Associated With Survival Following the Initiation of Immune Checkpoint Inhibitor Therapy in Patients With Non-small Cell Lung Cancer

治疗前中性粒细胞与淋巴细胞比值（NLR）及其变化与非小细胞肺癌患者开始免疫检查点抑制剂治疗后的生存率相关

doi:10.21873/cdp.10536

Inomata, Minehiko; Matsushiro, Yuki; Tanabe, Yuki; Hashizume, Moe; Azechi, Kenji; Murayama, Nozomu; Takata, Naoki; Seto, Zenta; Tokui, Kotaro; Okazawa, Seisuke; Imanishi, Shingo; Hayashi, Ryuji; Kainuma, Mosaburo

中性粒细胞

细胞生物学

免疫/内分泌

发表日期：2026

文献求助收藏

The Presence of Ganglionic Acetylcholine Receptor Antibodies in Sera from Patients with Functional Gastrointestinal Disorders: A Preliminary Study

功能性胃肠疾病患者血清中神经节乙酰胆碱受体抗体的存在：一项初步研究

期刊:Journal of Personalized Medicine

doi:10.3390/jpm14050485

Nakane, Shunya; Mukaino, Akihiro; Okumura, Yoshiaki; Hirosawa, Hiroaki; Higuchi, Osamu; Matsuo, Hidenori; Kainuma, Mosaburo; Nakatsuji, Yuji

发表日期：2024

文献求助收藏

The Impact of an Undergraduate Community-Based Medical Education Program in a Japanese Urban City

本科生社区医学教育项目对日本某城市的影响

期刊:Cureus Journal of Medical Science

影响因子:1.3

doi:10.7759/cureus.54204

Hiramine, Satoshi; Nagata, Masaharu; Kainuma, Mosaburo

发表日期：2024

文献求助收藏

Metabolic changes in the plasma of mild Alzheimer's disease patients treated with Hachimijiogan

服用八味地黄丸治疗的轻度阿尔茨海默病患者血浆代谢变化

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2023.1203349

Kainuma, Mosaburo; Kawakatsu, Shinobu; Kim, Jun-Dal; Ouma, Shinji; Iritani, Osamu; Yamashita, Ken-Ichiro; Ohara, Tomoyuki; Hirano, Shigeki; Suda, Shiro; Hamano, Tadanori; Hieda, Sotaro; Yasui, Masaaki; Yoshiiwa, Aoi; Shiota, Seiji; Hironishi, Masaya; Wada-Isoe, Kenji; Sasabayashi, Daiki; Yamasaki, Sho; Murata, Masayuki; Funakoshi, Kouta; Hayashi, Kouji; Shirafuji, Norimichi; Sasaki, Hirohito; Kajimoto, Yoshinori; Mori, Yukiko; Suzuki, Michio; Ito, Hidefumi; Ono, Kenjiro; Tsuboi, Yoshio

阿尔茨海默症

发表日期：2023

文献求助收藏

An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease

一项探索性、开放标签、随机、多中心试验，研究八味地黄丸对轻度阿尔茨海默病的疗效

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2022.991982

Kainuma, Mosaburo; Ouma, Shinji; Kawakatsu, Shinobu; Iritani, Osamu; Yamashita, Ken-Ichiro; Ohara, Tomoyuki; Hirano, Shigeki; Suda, Shiro; Hamano, Tadanori; Hieda, Sotaro; Yasui, Masaaki; Yoshiiwa, Aoi; Shiota, Seiji; Hironishi, Masaya; Wada-Isoe, Kenji; Sasabayashi, Daiki; Yamasaki, Sho; Murata, Masayuki; Funakoshi, Kouta; Hayashi, Kouji; Shirafuji, Norimichi; Sasaki, Hirohito; Kajimoto, Yoshinori; Mori, Yukiko; Suzuki, Michio; Ito, Hidefumi; Ono, Kenjiro; Tsuboi, Yoshio

阿尔茨海默症

发表日期：2022

文献求助收藏

Basic pharmacological mechanisms and clinical evidence of the efficacy of hochuekkito against infectious diseases and its potential for use against COVID‐19

补中益气汤治疗传染病的基本药理机制和临床疗效证据及其在治疗新冠肺炎中的应用潜力

期刊:Aging Cell

影响因子:7.1

doi:10.1111/acel.14337

Tanaka, Sakiho; Elgaabari, Alaa; Seki, Miyumi; Kuwakado, So; Zushi, Kahona; Miyamoto, Junri; Sawano, Shoko; Mizunoya, Wataru; Ehara, Kenshiro; Watanabe, Naruha; Ogawa, Yohei; Imakyure, Hikaru; Fujimaru, Reina; Osaki, Rika; Shitamitsu, Kazuki; Mizoguchi, Kaoru; Ushijima, Tomoki; Maeno, Takahiro; Nakashima, Takashi; Suzuki, Takahiro; Nakamura, Mako; Anderson, Judy E; Tatsumi, Ryuichi; Takayama, Shin; Kikuchi, Akiko; Makino, Toshiaki; Kainuma, Mosaburo; Namiki, Takao; Ito, Takashi

发表日期：2021

文献求助收藏

Basic pharmacological mechanisms and clinical evidence of the efficacy of hochuekkito against infectious diseases and its potential for use against COVID‐19

补中益气汤治疗传染病的基本药理机制和临床疗效证据及其在治疗新冠肺炎中的应用潜力

期刊:Frontiers in Neurology

影响因子:2.8

doi:10.3389/fneur.2021.659064

Harvey, Susan; King, Mary D; Gorman, Kathleen M; Takayama, Shin; Kikuchi, Akiko; Makino, Toshiaki; Kainuma, Mosaburo; Namiki, Takao; Ito, Takashi

发表日期：2021

文献求助收藏

A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)

一项关于使用汉方药预防 COVID-19 的多中心随机对照试验 (RCT) 研究方案的结构化摘要（日本流行病综合管理预防研究：IMJEDI P1 研究）

doi:10.1186/s13063-020-04939-2

Namiki, Takao; Takayama, Shin; Arita, Ryutaro; Ishii, Tadashi; Kainuma, Mosaburo; Makino, Toshiaki; Mimura, Masaru; Yoshino, Tetsuhiro; Nogami, Tatsuya; Arai, Makoto; Sato, Juichi; Tanaka, Koichiro; Nakae, Hajime; Igari, Hidetoshi; Ozawa, Yoshihito; Shiko, Yuki; Kawasaki, Yohei; Nezu, Masahiko; Ito, Takashi

发表日期：2021

文献求助收藏

The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol

一项探索性、开放标签、标准治疗对照、随机分组、多中心试验，旨在评估八味地黄丸治疗轻度阿尔茨海默病的疗效和安全性：研究方案

期刊:Medicine

影响因子:1.4

doi:10.1097/MD.0000000000022370

Kainuma, Mosaburo; Funakoshi, Kouta; Ouma, Shinji; Yamashita, Ken-Ichiro; Ohara, Tomoyuki; Yoshiiwa, Aoi; Murata, Masayuki; Tsuboi, Yoshio

阿尔茨海默症

发表日期：2020

文献求助收藏

Competencies necessary for becoming a leader in the field of community medicine: a Japanese qualitative interview study

成为社区医学领域领导者所需具备的能力：一项日本定性访谈研究

期刊:BMJ Open

影响因子:2.3

doi:10.1136/bmjopen-2017-020082

Kainuma, Mosaburo; Kikukawa, Makoto; Nagata, Masaharu; Yoshida, Motofumi

发表日期：2018

文献求助收藏